Immune Intervention in Sepsis.

Area of Science:

• Immunology
• Infectious Diseases
• Critical Care Medicine

Background:

• Sepsis is a life-threatening immune response to infection, often leading to multiple organ dysfunction syndrome (MODS).
• Despite advances in diagnostics and supportive care, high morbidity and mortality persist, largely due to dysregulated immune responses.
• Current treatments focus on infection control and organ support, with no specific drugs approved for sepsis itself.

Purpose of the Study:

• To review recent research on immune responses in sepsis.
• To provide a theoretical foundation for developing novel sepsis treatments.
• To explore the potential of immunomodulatory interventions.

Main Methods:

• Literature review of recent research on sepsis and immune responses.
• Analysis of the role of immune dysregulation in sepsis pathogenesis.
• Synthesis of information on current and emerging therapeutic strategies.

Main Results:

• Abnormal immune responses, from inflammation to immunosuppression, are critical drivers of sepsis mortality.
• Significant progress has been made in pathogen detection and organ support.
• No specific drugs targeting the immune aspects of sepsis have been approved.

Conclusions:

• Optimizing treatment requires a dynamic approach integrating anti-infection measures, fluid management, organ support, and immunomodulation.
• Targeting immune responses holds promise for improving sepsis patient outcomes.
• Further research into immunomodulatory interventions is essential for advancing sepsis therapy.